Observational studyRadiology. Imaging cancer2026
CT-based Extranodal Extension for Nodal Staging and Prognostic Stratification in Surgically Resectable Esophageal Squamous Cell Carcinoma.
Observational study in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Refining Nodal Staging in Esophageal Squamous Cell Carcinoma with CT-based Extranodal Extension.Radiology. Imaging cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop and validate a structured CT-based grading system for imaging-identified extranodal extension (iENE) and assess its diagnostic accuracy and prognostic significance in esophageal squamous cell carcinoma. Materials and Methods In this retrospective multicenter study, preoperative CT examinations in patients with esophageal squamous cell carcinoma treated at four tertiary hospitals between January 2017 and December 2023 were reviewed. CT features evaluated included indistinct nodal margins, coalescent nodal mass, invasive encasement, halo sign, and black ring sign. Radiologic-pathologic node-by-node correlation was performed in the development cohort to assess diagnostic performance. The validation cohort consisted of an independent, multicenter patient population and was used to evaluate the prognostic value of iENE at the patient level. Logistic regression and receiver operating characteristic analyses were used to assess diagnostic performance, while overall survival was evaluated using Kaplan-Meier and Cox regression analyses. Results A total of 912 patients with esophageal squamous cell carcinoma were included, with 95 patients (mean age, 62 years ± 8; 75 male patients) in the development cohort and 817 patients (mean age, 62 years ± 9; 619 male patients) in the validation cohort. Coalescent nodal mass, invasive encasement, and black ring sign at CT demonstrated 100% specificity for pathologic ENE. An iENE score of 2 or higher achieved optimal diagnostic performance (sensitivity, 82% [36 of 44]; specificity, 90% [250 of 279]; accuracy, 89% [286 of 323]). Patients with high-risk iENE (score ≥2) had worse overall survival than those with low-risk disease in both the development cohort (hazard ratio, 8.83; 95% CI: 3.30, 23.64;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.